The National Association of Boards of Pharmacy® (NABP®) today issued a report highlighting a connection between the proliferation of rogue online drug sellers and the prescription drug abuse epidemic.
Human Medications, Human Drugs, Animal Medications, Animal Drugs, Pharmacy law, Pharmaceutical law, Compounding law, Sterile and Non Sterile Compounding 797 Compliance, Veterinary law, Veterinary Compounding Law; Health Care; Awareness of all Types of Compounding Issues; Pharmacy Benefit Managers (PBMs), Outsourcing Facilities Food and Drug Administration and Compliance Issues
Saturday, November 1, 2014
IACP's comments Docket ID: FDA-2013-N-1525 Bulk Drug Substances That May Be Used to Compound Drug Products in Accordance With Section 503A of the Federal Food, Drug, and Cosmetic Act; Request for Nominations
- Thank you for the opportunity to submit our comments on FDA’s request for a list of bulk drug substances that may be used in pharmacy compounding as defined within Section 503A of...
- Public Submission
- Posted:08/11/2014
- ID:FDA-2013-N-1525-0107
Third Question of the Day November 1, 2014 Are there any compounding pharmacies that verify Certificates of Analyses (CoA) data with further testing? If so, is the testing for all parameters and results listed on the CoA's? If no verification is done and there is no warranty, isn't this problematic because of grey markets, counterfeit and substandard bulks that threaten the supply chain?
Subscribe to:
Posts (Atom)